Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Cavalli

Showing results (31-40 of 136) with videos related to

Pageof 14
Sort By:
The American Journal of Medicine|April 24, 2014
A bitter effect: thrombocytopenia induced by a quinidine-containing beverageGiulio Cavalli, Barbara Guglielmi, Maurilio Ponzoni, et al.
European Journal of Internal Medicine|April 14, 2015
Erdheim-Chester diseaseCorrado Campochiaro, Alessandro Tomelleri, Giulio Cavalli, et al.
Expert Opinion on Drug Safety|October 20, 2020
Current treatment options and safety considerations when treating adult-onset Still's diseaseGiulio Cavalli, Nicola Farina, Corrado Campochiaro, et al.
International Journal of Cardiology|December 19, 2017
Prevalence of Takayasu arteritis in young women with acute ischemic heart diseaseGiulio Cavalli, Alessandro Tomelleri, Davide Di Napoli, et al.
Frontiers in Immunology|June 29, 2018
Myocarditis: An Interleukin-1-Mediated Disease?Giacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
European Journal of Internal Medicine|August 5, 2018
Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case seriesAlessandro Tomelleri, Corrado Campochiaro, Giacomo De Luca, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 20, 2007
Adenocarcinoma arising in a lingual foregut duplication cystJapa Volchok, Azul Jaffer, Teri Cooper, et al.
The Lancet. Rheumatology|February 1, 2021
Mavrilimumab for severe COVID-19 - Authors' replyGiacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
Annals of Internal Medicine|August 4, 2018
Treatment of Dilated Cardiomyopathy With Interleukin-1 InhibitionGiacomo De Luca, Corrado Campochiaro, Charles A Dinarello, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's diseaseCorrado Campochiaro, Nicola Farina, Alessandro Tomelleri, et al.
Pageof 14

Showing results (31-40 of 136) with videos related to

Sort By:
Pageof 14
The American Journal of Medicine|April 24, 2014
A bitter effect: thrombocytopenia induced by a quinidine-containing beverageGiulio Cavalli, Barbara Guglielmi, Maurilio Ponzoni, et al.
European Journal of Internal Medicine|April 14, 2015
Erdheim-Chester diseaseCorrado Campochiaro, Alessandro Tomelleri, Giulio Cavalli, et al.
Expert Opinion on Drug Safety|October 20, 2020
Current treatment options and safety considerations when treating adult-onset Still's diseaseGiulio Cavalli, Nicola Farina, Corrado Campochiaro, et al.
International Journal of Cardiology|December 19, 2017
Prevalence of Takayasu arteritis in young women with acute ischemic heart diseaseGiulio Cavalli, Alessandro Tomelleri, Davide Di Napoli, et al.
Frontiers in Immunology|June 29, 2018
Myocarditis: An Interleukin-1-Mediated Disease?Giacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
European Journal of Internal Medicine|August 5, 2018
Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case seriesAlessandro Tomelleri, Corrado Campochiaro, Giacomo De Luca, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 20, 2007
Adenocarcinoma arising in a lingual foregut duplication cystJapa Volchok, Azul Jaffer, Teri Cooper, et al.
The Lancet. Rheumatology|February 1, 2021
Mavrilimumab for severe COVID-19 - Authors' replyGiacomo De Luca, Giulio Cavalli, Corrado Campochiaro, et al.
Annals of Internal Medicine|August 4, 2018
Treatment of Dilated Cardiomyopathy With Interleukin-1 InhibitionGiacomo De Luca, Corrado Campochiaro, Charles A Dinarello, et al.
Clinical and Experimental Rheumatology|March 29, 2022
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's diseaseCorrado Campochiaro, Nicola Farina, Alessandro Tomelleri, et al.
Pageof 14